Brimonidine Tartrate Solution/ Drops
Product Images NDC 24208-411

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 24208-411). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6c8473d2 340c 4861 Ac53 D715b52ca139 00

Packaging label for Brimonidine Tartrate Ophthalmic Solution 0.2%, a sterile ophthalmic solution in 15 mL size. The label includes product details, active ingredient concentration (2 mg/mL), usage instructions, and storage information. It is distributed by Bausch & Lomb Incorporated.*

FDA Label Image

Dbad897a 1c53 4cf2 836d C99c0bdfc1ba 00

A label safety warning panel stating: 'DO NOT USE IF IMPRINTED "Protective Seal" WITH YELLOW IS NOT INTACT.' This text is presented within a bordered box, accompanied by a small icon resembling a mortar and pestle.*

FDA Label Image

Image 01

Chemical structure diagram of Brimonidine Tartrate showing the molecular formula C11H10BrN5 · C4H6O6 and molecular weight of 442.22 g/mol. The structure depicts the arrangement of atoms including bromine (Br), nitrogen (N), oxygen (O), and hydrogen (H) in the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.